The effect of hydroxyapatite in biopolymer-based scaffolds on release of naproxen sodium
Vahid Asadian-Ardakani
Materials and Biomaterials Research Center, Tehran, Iran
Search for more papers by this authorCorresponding Author
Samaneh Saber-Samandari
Department of Chemistry, Eastern Mediterranean University, Gazimagusa, 10 TRNC via Mersin, Turkey
Correspondence to: S. Saber-Samandari; e-mail: [email protected] or S. Saber-Samandari; e-mail: [email protected]Search for more papers by this authorCorresponding Author
Saeed Saber-Samandari
New Technologies Research Center, Amirkabir University of Technology, Tehran, Iran
Correspondence to: S. Saber-Samandari; e-mail: [email protected] or S. Saber-Samandari; e-mail: [email protected]Search for more papers by this authorVahid Asadian-Ardakani
Materials and Biomaterials Research Center, Tehran, Iran
Search for more papers by this authorCorresponding Author
Samaneh Saber-Samandari
Department of Chemistry, Eastern Mediterranean University, Gazimagusa, 10 TRNC via Mersin, Turkey
Correspondence to: S. Saber-Samandari; e-mail: [email protected] or S. Saber-Samandari; e-mail: [email protected]Search for more papers by this authorCorresponding Author
Saeed Saber-Samandari
New Technologies Research Center, Amirkabir University of Technology, Tehran, Iran
Correspondence to: S. Saber-Samandari; e-mail: [email protected] or S. Saber-Samandari; e-mail: [email protected]Search for more papers by this authorAbstract
A scaffold capable of controlling drug release is highly desirable for bone tissue engineering. The objective of this study was to develop and characterize a highly porous biodegradable scaffold and evaluate the kinetic release behavior for the application of anti-inflammatory drug delivery. Porous scaffolds consisting of chitosan, poly(acrylic acid), and nano-hydroxyapatite were prepared using the freeze-drying method. The nanocomposite scaffolds were characterized for structure, pore size, porosity, and mechanical properties. The nanocomposite scaffolds were tested and characterized using Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), energy-dispersive analysis of X-ray (EDS), X-ray diffraction (XRD) analysis, and tensile test instrument. The results showed that the pores of the scaffolds were interconnected, and their sizes ranged from 145 µm to 213 μm. The mechanical properties were found close to those of trabecular bone of the same density. The ability of the scaffolds to deliver naproxen sodium as a model drug in vitro was investigated. The release profile of naproxen sodium was measured in a phosphate-buffered saline solution by a ultra-violet spectrophotometer that was controlled by the Fickian diffusion mechanism. These results indicated that the chitosan-graft-poly(acrylic acid)/nano-hydroxyapatite scaffold may be a promising biomedical scaffold for clinical use in bone tissue engineering with a potential for drug delivery. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2992–3003, 2016.
REFERENCES
- 1 Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am A 2001; 83: 803–816.
- 2 Nagai N, Kumasaka N, Kawashima T, Kaji H, Nishizawa M, Abe T. Preparation and characterization of collagen microspheres for sustained release of VEGF. J Mater Sci Mater Med 2010; 21: 1891–1898.
- 3 Tabata Y. The importance of drug delivery systems in tissue engineering. Pharm Sci Technol 2000; 3: 80–89.
- 4 Martínez-Vázquez FJ, Cabañas MV, Paris JL, Lozano D, Vallet-Regí M. Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration. Acta Biomater 2015; 15: 200–209.
- 5 Flynn GL, Yalkowski SH, Roseman TJ. Mass transfer phenomena and models: Theoretical concepts. J Pharm Sci 1974; 63: 479–510.
- 6 Langer R. Drug delivery and targeting. Nature 1998; 392: 5–10.
- 7 Orlovskii VP, Komlev VS, Barinov SM. Hydroxyapatite and hydroxyapatite-based ceramics. Inorg Mater 2002; 38: 973–984.
- 8 Saber-Samandari S, Nezafati N, Saber-Samandari S. The effective role of hydroxyapatite-based composites in anticancer drug-delivery systems. Crit Rev Ther Drug 2016; 33: 41–75.
- 9 Ducheyne P, Radin S, King L. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. J Biomed Mater Res 1993; 27: 25–34.
- 10 Nabipour Z, Nourbakhsh MS, Baniasadi M. Synthesis, characterization and biocompatibility evaluation of hydroxyapatite-gelatin polyLactic acid ternary nanocomposite. Nanomed J 2016; 3: 127–134.
- 11 Saber-Samandari S, Saber-Samandari S, Ghonjizade-Samani F, Aghazadeh J, Sadeghi A. Bioactivity evaluation of novel nanocomposite scaffolds for bone tissue engineering: The impact of hydroxyapatite. Ceram Int 2016; 42: 11055–11062.
- 12 Niu X, Feng Q, Wang M, Guo X, Zheng Q. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release 2009; 134: 111–117.
- 13 Ubaidulla U, Khar RK, Ahmad FJ, Tripathi P. Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology. Pharm Dev Technol 2009; 14: 96–105.
- 14 Kong M, Chen XG, Liu CS, Liu CG, Meng XH, Yule J. Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli. Colloid Surf B: Biointerface 2008; 65: 197–202.
- 15 Park Y, Kim MH, Park SC, Cheong H, Jang MK, Nah JW. Investigation of the antifungal activity and mechanism of action of LMWS-chitosan. J Microbiol Biotechnol 2008; 18: 1729–1734.
- 16 Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010; 56: 290–299.
- 17 Dorj B, Won JE, Purevdorj O, Patel KD, Kim JH, Lee EJ, Kim HW. A novel therapeutic design of microporous-structured biopolymer scaffolds for drug loading and delivery. Acta Biomater 2014; 10: 1238–1250.
- 18 Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413–3431.
- 19 Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. Injectable PLGA microsphere/calcium phosphate cements: Physical properties and degradation characteristics. J Biomater Sci Polym Ed 2006; 17: 1057–1074.
- 20 Wang L, Li C. Preparation and physicochemical properties of a novel hydroxyapatite/chitosan-silk fibroin composite. Carbohydr Polym 2007; 68: 740–745.
- 21 Kong L, Gao Y, Lu G, Gong Y, Zhao N, Zhang X. A study on the bioactivity of chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Euro Polym J 2006; 42: 3171–3179.
- 22 Liu TY, Chen SY, Li JH, Liu DM. Study on drug release behavior of CDHA/chitosan nanocomposites—Effect of CDHA nanoparticles. J Control Release 2006; 112: 88–95.
- 23 Muldaerjee DP, Tunlde AS, Roberts RA. An animal evaluation of a paste of chitosan glutamate and hydroxyapatite as a synthetic bone graft material. J Biomed Mater Res B 2006; 67: 603.
- 24 Zan QF, Wang C, Dong LM, Tian JM. Preparation and Characterization of Biodegradable β-TCP-Based Composite Microspheres as Bone Tissue Engineering Scaffolds. Key Eng Mater 2007; 336–338:1646–1649.
- 25 Wu T, Nan K, Chen J, Jin D, Jiang S, Zhao P, Xu J, Du H, Zhang X, Li J, Pei G. A new bone repair scaffold combined with chitosan/hydroxyapatite and sustained releasing icariin. Chin Sci Bull 2009; 54: 2953–2961.
- 26 Sadlej-Sosnowska N, Kozerski L, Bednarek E, Sitkowski J. Fluorometric and NMR studies of the naproxen-cyclodextrin inclusion complexes in aqueous solutions. J Incl Phenom Macrocycl Chem 2000; 37: 383–394.
- 27 Mello VAD, Ricci-Junior E. Encapsulation of naproxen in nonstructured system: Structural characterization and in vitro release studies. Quim Nova 2011; 34: 933–939.
- 28 Pulat M, Eksi H. Determination of swelling behavior and morphological properties of poly(acrylamide-co-itaconicacid) and poly(acrylicacid-co-itaconicacid) copolymeric hydrogels. J Appl Polym Sci 2006; 102: 5994–5999.
- 29
Zhang R,
Ma PX. Poly(a-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999; 44: 446–455.
10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 30 Saber-Samandari S, Gulcan HO, Saber-Samandari S, Gazi M. Efficient removal of anionic and cationic dyes from an aqueous solution using pullulan-graft-polyacrylamide porous hydrogel. Water Air Soil Pollut 2014; 225: 2177–2191.
- 31 Siepmann J, Peppas NA. Preface: Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev 2001; 48: 137–138.
- 32 Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 2010; 7: 429–444.
- 33 Saber-Samandari S, Gazi M, Yilmaz O. Synthesis and characterization of chitosan-graft-poly(n-allyl maleamic acid) hydrogel membrane. Water Air Soil Pollut 2013; 224: 1624.
- 34 Saber-Samandari S, Yilmaz O, Yilmaz E. Photoinduced graft copolymerization onto chitosan under heterogeneous conditions. J Macromol Sci A 2012; 49: 591–598.
- 35 Karkeh-abadi F, Saber-Samandari S, Saber-Samandari S. The impact of functionalized CNT in the network of sodium alginate-based nanocomposite beads on the removal of Co(II) ions from aqueous solutions. J Hazard Mater 2016; 312: 224–233.
- 36 Eid M, Abdel-Ghaffar MA, Dessouki AM. Effect of maleic acid content on the thermal stability, swelling behaviour and network structure of gelatin-based hydrogels prepared by gamma irradiation. Nucl Instrum Methods Phys Res B 2009; 267: 91–98.
- 37 Xie YT, Wang AQ. Preparation and swelling behaviour of chitosan-g-poly(acrylic acid)/muscovite superabsorbent composites. Iran Polym J 2010; 19: 131–141.
- 38 Saber-Samandari S, Alamara K, Saber-Samandari S, Gross KA. Micro-Raman spectroscopy shows how the coating process affects the characteristics of hydroxylapatite. Acta Biomater 2013; 9: 9538–9546.
- 39 Saber-Samandari S, Saber-Samandari S, Kiyazar S, Aghazadeh J, Sadeghi A. In vitro evaluation for apatite forming ability of cellulose-based nanocomposite scaffolds for bone tissue engineering. Int J Biol Macromol 2016; 86: 434–442.
- 40 Saber-Samandari S, Alamara K, Saber-Samandari S. Calcium phosphate coatings: Morphology, micro-structure and mechanical properties. Ceram Int 2014; 40: 563–572.
- 41 Jana S, Florczyk SJ, Leung M, Zhang M. High-strength pristine porous chitosan scaffolds for tissue engineering. J Mater Chem 2012; 22: 6291–6299.
- 42 Li Y, Yang C, Zhao H, Qu S, Li X, Li Y. New developments of Ti-based alloys for biomedical applications. Materials 2014; 7: 1709–1800.
- 43 Lee S, Porter M, Wasko S, Lau G, Chen PY, Novitskaya EE, Tomsia AP, Almutairi A, Meyers MA, McKittrick J. Potential bone replacement materials prepared by two methods. Mater Res Soc Synp Proc 2012; 1418: 177–188.
- 44 Archana D, Upadhyay L, Tewari RP, Dutta J, Huang YB, Dutta PK. Chitosan-pectin-alginate as a novel scaffold for tissue engineering applications. Indian J Biotechnol 2013; 12: 475–482.
- 45 Saber-Samandari S, Saber-Samandari S, Heydaripour S, Abdouss M. Novel carboxymethyl cellulose based nanocomposite membrane: Synthesis, characterization and application in water treatment. J Environ Manage 2016; 166: 457–465.
- 46 Peter M, Ganesh N, Selvamurugan N, Nair SV, Furuike T, Tamura H, Jayakumar R. Preparation and characterization of chitosan-gelatin/nanohydroxyapatite composite scaffolds for tissue engineering applications. Carbohydr Polym 2010; 80: 687–694.
- 47 Rani M, Agarwal A, Negi YS. Review: Chitosan based hydrogel polymeric beads as a drug delivery system. Bioresources 2010; 5: 2765–2807.
- 48 Chime Salome A, Onunkwo Godswill C, Onyishi Ikechukwu I. Kinetics and mechanisms of drug release from swellable and non swellable matrices: A review. Res J Pharm Biol Chem Sci 2013; 4: 97–103.